[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353927-105":59,"doc-detail-353927-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cancer-genetic-testing-uptake-in-the-primary-care-setting-patient-perspectives-on-barriers-and-facilitators-throughout-the-testing-process","Cancer genetic testing uptake in the primary care setting: Patient perspectives on barriers and facilitators throughout the testing process","","Genetic testing for gene variants linked to hereditary cancers supports prevention, early detection, and treatment, yet remains insufficiently integrated into primary care. To identify patient-level barriers and facilitators across the testing pathway, a thematic analysis was conducted using semi-structured interviews with 31 participants in the EDGE study. Readiness changed over brief follow-up periods. Barriers included limited access to technology and incomplete responses due to knowledge gaps about biological relatives. Decliners emphasized privacy, insurance discrimination, and psychological burden, while test completers were motivated by family cancer history and perceived preventive options. Results suggest re-offering strategies over time.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-genetic-testing-uptake-in-the-primary-care-setting-patient-perspectives-on-barriers-and-facilitators-throughout-the-testing-process/353927/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-genetic-testing-uptake-in-the-primary-care-setting-patient-perspectives-on-barriers-and-facilitators-throughout-the-testing-process/353927.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of this study on genetic testing in primary care?","Question",{"text":113,"@type":114},"The study explored patient-level barriers and facilitators across the genetic testing process in primary care settings, focusing on how these factors influenced uptake.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did participants differ based on their progress through the testing process?",{"text":118,"@type":114},"Interviews included patients who had not completed risk assessment, those who were ineligible after completing risk assessment, those who declined testing, and those who completed testing.",{"name":120,"@type":111,"acceptedAnswer":121},"What barriers and concerns affected patients who did not complete genetic testing?",{"text":122,"@type":114},"Patients cited limited access to technology, difficulties providing complete information about biological relatives, and concerns about privacy, insurance discrimination, and possible psychological burden.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353927,1790407512,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","DOI: 10. 1002/jgc4 .70195  \nOR I G I NAL ART I C L E  \nCancer genetic testing uptake in the primary care setting: Patient perspectives on barriers and facilitators throughout the testing process  \nTesla N. Theoryn1  | Faith Beers1 | Emerson J. Dusic1 | Catharine Wang2 | DaLaina Cameron1 | Heather Harris1 | Sarah Knerr1 | Elizabeth M. Swisher1 | Susan Brown Trinidad1  \n1University of Washington, Seattle, Washington, USA  \n2Boston University School of Public Health, Boston, Massachusetts, USA  \nCorrespondence  \nTesla N. Theoryn, University of Washington, 1959 NE Pacific St, Seattle, WA 98195, USA.  \nEmail: [theoryn@uw.edu](theoryn@uw.edu)  \nFunding information  \nCancer Moonshot, Grant/Award Number: 1U01CA232795-01A1  \nAbstract  \nGenetic testing for gene variants associated with hereditary cancers can help with cancer prevention, early detection, and treatment. However, testing has not been well integrated into primary care settings where its preventative impact can be realized. To explore patient-level barriers and facilitators throughout the genetic testing process in primary care settings, we conducted a thematic analysis of semi-structured interviews with 31 patients within the Early Detection of Genetic Risk (EDGE) study who had not completed the risk assessment (n = 2), had completed the risk assessment but were ineligible (n = 8), had declined testing (n = 10), and had completed testing (n = 11) . Interviewees were broadly interested in genetic testing. Those who did not complete the risk assessment cited limited access to technology, exacerbated by health and financial struggles. Several interviewees who completed the risk assessment but were deemed ineligible for testing indicated that their lack of knowledge about biological relatives prevented complete responses to the risk assessment. Those who opted out of testing cited concerns over privacy, insurance discrimination, and potential psychological burden. Notably, the majority who declined testing were unsure if they would refuse again in the future, and three went on to request genetic testing after being invited to complete an interview. Those who changed their minds about testing stated changes in life circumstances (such as obtaining life insurance) that facilitated openness to testing. Patients who completed testing shared similar concerns to those who declined but were motivated by their familial cancer history and believed genetic testing could lead to preventative options. A key finding of this study was that patient readiness for testing changed over relatively brief follow-up times. These results highlight the need for practicable approaches to re-offering genetic testing to individuals over time.  \nK E Y WO R D S  \ngenetic testing, hereditary cancer, provider communication  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s) . Journal of Genetic Counseling published by Wiley Periodicals LLC on behalf of National Society of Genetic Counselors.  \n1 | INTRODUCTION  \nFor over 20 years, cancer has been a leading cause of morbidity and mortality in the United States (CDC, 2023), with inherited variants associated with 5%–10% of cases (Garber & Offit, 2005) . Proactive identification of individuals who carry such variants is critical to reducing hereditary cancer burden. Genetic testing for hereditary cancer risk (GT) can facilitate interventions aimed at early detection and prevention, such as enhanced screenings and risk-reducing surgeries (Cragun et al., 2020) . The reach of early identification can be increased by extending GT from primarily cancer care settings to medical spaces focused on prevention, such as primary care (Chambers et al., 2015; Dusic et al., 2022; Petry et al., 2019) . In the primary care setting, for example, providers can identify patients who may benefit from GT based ","cbCaijqGOGI6n2iV","https://ap.wps.com/l/cbCaijqGOGI6n2iV","pdf",835550,12,"English","# Abstract\n## Introduction","[{\"question\":\"What was the purpose of this study on genetic testing in primary care?\",\"answer\":\"The study explored patient-level barriers and facilitators across the genetic testing process in primary care settings, focusing on how these factors influenced uptake.\"},{\"question\":\"How did participants differ based on their progress through the testing process?\",\"answer\":\"Interviews included patients who had not completed risk assessment, those who were ineligible after completing risk assessment, those who declined testing, and those who completed testing.\"},{\"question\":\"What barriers and concerns affected patients who did not complete genetic testing?\",\"answer\":\"Patients cited limited access to technology, difficulties providing complete information about biological relatives, and concerns about privacy, insurance discrimination, and possible psychological burden.\"}]","Cancer genetic testing uptake in the primary care setting: Patient perspectives on barriers and facilitators throughout the testing process | PDF",1790107975]